| |
VRX496 Update, Novel HIV Gene Therapy
|
| |
| |
VIRxSYS Announces Completion of Phase I Study of VRX496, Novel HIV ...
The viral vector plus antisense is called VRX496. The antisense genetic medicine blocks HIV replication in CD4 T cells, which would otherwise be destroyed ...
www.natap.org/2005/newsUpdates/050505-01.htm -
HIV gene therapy study 'shows promise'
The researchers are now recruiting for a second trial of the treatment - dubbed VRX496. This time it will be tested on patients whose HIV load is already ...
www.natap.org/2006/newsUpdates/110906_03.htm
|
|
| |
| |
|
|
|
